Molecular screening for potential selective antagonists of TRPA₁ ion channel

The article discusses the results of analysis a number of candidate molecules for TRPA₁ ion channel selective antagonists using molecular modeling methods of high throughput screening. The study determined their mechanisms of action and specific activity in cells with overexpression of TRPA₁ ion channel. It demonstrated antagonistic activity of test substances in relation to TRPA₁ ion channel based on the results of molecular screening of biologically active molecules and their comparison with the reference antagonist. The highest activity was demonstrated by the substance with the ZC02-0012 code which was regarded as the main candidate that could be recommended for use in further safety and selectivity studies using in vitro tests and subsequent in vivo experiments aimed at determining its activity and safety in relation to living systems.

ионный канал TRPA₁, боль, ноцицепция, воспаление, высокопроизводительный молекулярный скрининг, молекулы-кандидаты в селективные антагонисты ионного канала TRPA₁, TRPA₁ ion channel, pain, nociception, inflammation, high throughput screening, candidate molecules for selective antagonists of TRPA₁ ion channel

1. Tactics and emergency treatment of pain. Research and information material. Moscow: Association of Moscow universities; 2010 (in Russian).

2. Jordt SE, Bautista DM, Chuang HH, McKemy DD, Zygmunt PM, Hogestatt ED, et al. Mustard oils and cannabinoids excite sensory nerve fibres through the TRP channel ANKTM1. Nature 2004; 427(6971): 260–5.

3. Trevisani M, Siemens J, Materazzi S, Bautista DM, Nassini R, Campi B, et al. 4- Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci USA 2007; 104(33): 13519–24.

4. Shelukhina I, Mikhailov N, Abushik P, Nurulin L, Nikolsky EE, Giniatullin R. Cholinergic Nociceptive Mechanisms in Rat Meninges and Trigeminal Ganglia: Potential Implications for Migraine Pain. Front Neurol. 2017; (8): 163.

5. Bohonyi N, Pohoczky K, Szalontai B, Perkecz A, Kovacs K, Kajtar B, et al. Local upregulation of transient receptor potential ankyrin 1 and transient receptor potential vanilloid 1 ion channels in rectosigmoid deep infiltrating endometriosis. Mol Pain 2017; (13): 1744806917705564.

6. Asai Y, Holt JR, Geleoc GS. A quantitative analysis of the spatiotemporal pattern of transient receptor potential gene expression in the developing mouse cochlea. J Assoc Res Otolaryngol. 2010; 11(1): 27–37.

7. Matta JA, Cornett PM, Miyares RL, Abe K, Sahibzada N, Ahern GP. General anesthetics activate a nociceptive ion channel to enhance pain and inflammation. Proc Natl Acad Sci USA 2008; 105(25): 8784–9.

8. Beskhmelnitsyna EA, Pokrovsky MV, Korokin MV, Yakushev VI, Gudyrev OS. The biological role of ion channel TRPA1 in various pathological conditions. Belgorod State University Scientific Bulletin. Medicine. Pharmacy 2012; 20(22–3): 30–5 (in Russian).

9. Nie Y, Huang C, Zhong C, Wortley MA, Luo Y, Luo W, et al. Cigarette smoke extract (CSE) induces transient receptor potential ankyrin 1 (TRPA1) expression via activation of HIF1á in A549 cells. Free Radic Biol Med. 2016; (99): 498–507.

10. Nakao S, Mabuchi M, Wang S, Koqure Y, Shimizu T, Noguchi K, et al. Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor. Bioorg Med Chem Lett. 2017; 27(14): 3167–72.

11. Pryde DC, Marron BE, West CW, Reister S, Amato G, Yoger K, et al. Discovery of a Series of Indazole TRPA1 Antagonists. ACS Med Chem Lett. 2017; 8(6): 666–71.

12. Kravchenko DV, Beskhmelnitsyna EA, Korokin MV, Avtina TV, Sernov LN, Tishin AN, Kostina DA. Molecular screening of prospective candidates for TRPA1 ion channel selective antagonists. Research Result: Pharmacology and Clinical Pharmacology 2016; 2(1): 63–6.

13. Skerratt S. Recent Progress in the Discovery and Development of TRPA1 Modulators. Prog Med Chem. 2017; (56): 81–115.

14. Mukhopadhyay I, Kulkarni A, Aranake S, Karnik P, Shetty M, Thorat S, et al. Transient receptor potential ankyrin 1 receptor activation in vitro and in vivo by pro-tussive agents: GRC 17536 as a promising anti- tussive therapeutic. PLoS One 2014; 9(5): e97005.